Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea

Digital health startup Happy Health has raised $75 million in a Series A funding round to advance its AI-powered platform for continuous, home-based care. The investment was led by ARCH Venture Partners and OpenLoop. According to Paul Berns, a managing director at ARCH Venture Partners, "For decades, healthcare has waited until people are already sick to act." Happy Health believes it can change this paradigm.

The company's first application concentrates on sleep disorders, particularly sleep apnea. Its core product is the Happy Ring, a clinical-grade smart ring approved by the FDA in October 2024. Happy Health's platform goes beyond traditional sleep testing. The device continuously monitors over 2.8 million biometric measurements every night and uses AI and first-principles physiological models to identify meaningful changes in each individual's physiological baseline.

This approach allows Happy Health to diagnose conditions like obstructive sleep apnea (OSA) with 98% accuracy after just three nights of use. Rather than comparing patients to population averages, the platform focuses on whether a person's health metrics still align with their own individual baseline. This could enable earlier detection and management of a variety of chronic diseases, according to Happy Health executives.

The startup's platform is currently in-network with most major health insurance plans, including Blue Cross and Medicare. Founders Dustin Freckleton, M.D., and Paul Berns are determined to revolutionize healthcare by allowing physicians to identify diseases in their earliest stages, rather than waiting for symptoms to appear.